On Mar. 21, 2024, Eledon Pharmaceuticals announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a…
On Mar. 18, 2024, using advanced imaging techniques and in-depth clinical assessments, a research team at the National…
On Mar. 18, 2024, the U.S. Environmental Protection Agency (EPA) announced a final rule to prohibit ongoing uses…
On Mar. 18, 2024, the U.S. Food and Drug Administration approved Orchard Therapeutics’ Lenmeldy (atidarsagene autotemcel), the first…
On Mar. 14, 2024, the Institute for Health Metrics and Evaluation (IHME) released all-cause mortality, life expectancy, and…
On Mar. 13, 2024, researchers at the National Institutes of Health (NIH) announced they had discovered that symptoms…
On Mar. 13, 2024, the Fred Hutchinson Cancer Center announced that a blood test intended for screening for…
On Mar. 13, 2024, an unassuming brown bovine from the south of Brazil has made history as the…
On Mar. 11, 2024, the British Antarctic Survey reported that penguins on the sub-Antarctic Islands of South Georgia…
On Mar. 8, 2024, the U.S. Food and Drug Administration approved a new indication for use of Novo…
On Mar. 4, 2024, Hugel America announced it received U.S. Food and Drug Administration (FDA) approval on its…
On Mar. 1, 2024, researchers at the National Institutes of Health (NIH) announced they had identified antibodies targeting…
On Feb. 28, 2024, the CDC Advisory Committee on Immunization Practices’ (ACIP) announced a recommendation for adults ages…
On Feb. 28, 2024, the U.S. Centers for Disease Control and Preventionï¾’s (CDC) Advisory Committee on Immunization Practices…
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM) awarded $56 million to fund various clinical…
On Feb. 22, 2024, the University of California, San Francisco (UC, San Francisco) launched the world’s first tissue…
On Feb. 21, 2024, the Fred Hutchinson Cancer Center announced it was at the helm of a new…
On Feb. 21, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved $98,592,155…
On Feb. 16. 2024, Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair…
On Feb. 16, 2024, the U.S. Centers for Disease Control and Prevention announced that ten people infected with…
On Feb. 13, 2024, CRISPR Therapeutics announced that the European Commission had granted conditional marketing authorization to CASGEVY…
On Feb. 9, 2024, the state of Alaska Department of Health Alaska Department of Health confirmed the first…
On Feb. 6, 2024, Oregon Health & Science University (OHSU) announced research that revealed as much as a…
On Feb. 5, 2024, CSL and and Arcturus Therapeutics announced the results of a follow-up analysis of a…
On Feb. 2, 2024, Chinese scientists announced they have assembled the world’s most detailed human genome yet, a…
On Jan. 27, 2024, the National Health Commission of the People’s Republic of China notified the World Health…
On Jan. 25, 2024, dozens of noted scientists, philanthropists, and Washington University, state and local leaders celebrated the…
On Jan. 24, 2024, Oregon Health & Science University announced that Pamela Runner, 77, of Corvallis, became the…
On Jan. 22, 2024, the University of California, Davis announced the first reported outbreak of high pathogenicity H5N1…
On Jan. 16, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved CRISPR Therapeutics’ CASGEVY…